drugset / Trial / NCT01516216

Study of Vitamin D in Untreated Metastatic Colorectal Cancer

NCT01516216 ↗

Phase 2 Completed 139 enrolled Dana-Farber Cancer Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective, randomized, double-blind phase II trial to evaluate the efficacy and safety of two doses of vitamin D supplementation in combination with standard chemotherapy in participants with previously-untreated metastatic colorectal adenocarcinoma.

Timeline

Start
2012-04-13
Primary completion
2019-11-09
Completion
2019-11-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bevacizumab Monoclonal antibody — Intravenous
Comparator Leucovorin Small molecule — Intravenous
Comparator Oxaliplatin Small molecule — Intravenous
Comparator fluorouracil Small molecule — Intravenous

Indications